Myriad’s BRCA Gene Patent Wars Continue – A New Entrant Joins the Fray
- Kirk Hartley

- Oct 9, 2013
- 1 min read
The Myriad BRCA gene patent wars are continuing, and a new entrant has started a new fray by suing Myriad in a declaratory judgment suit. The Genomics Law Report provides a cogent summary.


Comments